Skip to content

Glossary

Triglycerides

Triglycerides are fats built from one glycerol molecule and three fatty acids. They are the main component of body fat, and their concentration in the blood is studied as a marker of cardiovascular risk.

What it means in practice

Chemically, a triglyceride is an ester formed from glycerol and three fatty acid groups [4]. In body-composition terms, fat mass consists mainly of triglycerides [1].

In the blood, triglycerides are measured in plasma or serum [2]. A 2015 review says moderately raised levels (2-10 mmol/l, or millimoles per liter) signal increased risk of cardiovascular disease or the presence of non-alcoholic steatohepatitis, a liver condition, and very high levels (more than 10 mmol/l) signal a risk of pancreatitis [2]. Lab reports do not all use this unit, so check the unit before comparing a result with these figures. Many genetic and nongenetic factors regulate the concentration [2]. Triglycerides are also tightly linked with other metabolic factors, including atherogenic remnant lipoproteins and small LDL particles, and the review says this makes the independent role of triglycerides in cardiovascular disease difficult to evaluate [2].

Why it matters when reading nootropics research

On NootropicsWork, triglycerides come up mainly on the omega-3 page. A Cochrane review of 86 randomized trials with 162,796 participants assessed the effects of omega-3 intake on outcomes that included lipids [3]. Blood triglycerides are a graded outcome there, and that page reports what the review found.

A triglyceride result is a marker, not a health event. A change in blood triglycerides tells you about one risk factor that is entangled with others [2]. The same Cochrane review assessed all-cause mortality and cardiovascular events as outcomes in their own right, separately from lipids [3].

References

  1. Prado CM, Gonzalez MC, Norman K, et al. Methodological standards for body composition-an expert-endorsed guide for research and clinical applications: levels, models, and terminology. Am J Clin Nutr. 2025.PMID 40754386DOI 10.1016/j.ajcnut.2025.05.022Tier 1, narrative review
  2. Piťha J, Kovář J, Blahová T. Fasting and nonfasting triglycerides in cardiovascular and other diseases. Physiol Res. 2015.PMID 26680665DOI 10.33549/physiolres.933196Tier 1, narrative review
  3. Abdelhamid AS, Brown TJ, Brainard JS, et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2020.PMID 32114706DOI 10.1002/14651858.CD003177.pub5Tier 1, meta-analysis
  4. National Library of Medicine (NIH). MeSH descriptor: Triglycerides (D014280), scope note. not shown (MeSH 2026 vocabulary).SourceTier 1

Articles that mention this term

All glossary terms